Key Market Indicators
**Czech Insulin Imports Projected to Surge to $191 Million by 2028** **Prague** – The import value of insulin to the Czech Republic is projected to rise to approximately $191 million by 2028, up from around $168 million in 2023. This marks an average annual growth rate of 1.9%. Since 1998, the demand for insulin in the Czech Republic has shown a consistent increase, averaging a 2.6% year-on-year growth. **Czech Insulin Exports to Reach $78 Million by 2028** Czech insulin exports are also on the rise. The export value is expected to climb to about $78 million by 2028, up from nearly $66 million in 2023, with an average annual growth rate of 2.6%. Since 1998, the supply of insulin from the Czech Republic has increased at an average rate of 2.9% annually. In 2023, the Czech Republic ranked 10th in global insulin exports, with the United Kingdom leading at approximately $66 million. France, Italy, and China followed in second, third, and fourth place, respectively.
